First look: new eczema drug tested in healthy volunteers
NCT ID NCT06214481
Summary
This early-stage study tested a single dose of an experimental drug called rocatinlimab in 20 healthy Chinese adults. The main goal was to see how the drug moves through the body and to check for any immediate side effects. This information helps researchers understand the drug's basic safety profile before testing it in people with atopic dermatitis (eczema).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Affiliated to Fudan University?
Shanghai, 200040, China
Conditions
Explore the condition pages connected to this study.